Insights
Insights From Our Experts
Articles
The Art of Simplifying Pharmacovigilance – Part V: Deconstructing Automation
The use of automation continues to be on the rise, and that trajectory is not slowing down anytime soon, if ever. In relation to pharmacovigilance, automation’s ascent and how it is impacting the industry is especially…
The Rising Demand for Light Medical Aesthetic in China
“The Rising Demand for Light Medical Aesthetic in China” provides a captivating insight into the surging popularity of non-surgical medical aesthetics in China. The article highlights the rapid growth of the medical aesthetic market and the…
Revolutionizing Vaccines: The Rise of mRNA Technology in China
Key Contributors: Robin Arnold, Executive Vice President; Renyang Liu, Engagement Manager; Nicole Li, Analyst Discover how mRNA technology is transforming the field of vaccines in China. From the evolution of vaccine development to the rapid progress…
Maximizing Potential: Essential Steps for Successful Commercialization of Cell and Gene Therapies
Introduction Cell and gene therapy (CGT) products have significantly enhanced the quality of life for millions of patients impacted by medical conditions that are untreatable with traditional medicines or surgeries such as certain cancers, inherited and…
Maximizing Product Launch Success: The Importance of Conducting Comprehensive Business Simulation Exercises
Product launch preparedness is a vital aspect of bringing new products to market, particularly in the pharmaceutical industry where patients’ health and well-being can be impacted, in addition to the brand’s success and overall reputation. As…
The Art of Simplifying Pharmacovigilance – Part IV: Streamlining Vendor Engagement for Marketing Authorization Holders
It is often overlooked how many vendors a Marketing Authorization Holder (MAH) engages with. The more you spread your resources, the more scattered your focus becomes. Conversely, the more you concentrate your efforts, the more you…
The Art of Simplifying Pharmacovigilance – Part III: Unlocking Efficiency Through Consolidation
Just a few years ago, accessing entertainment on television was simple. However, the emergence of Over The Top applications for streaming content has made it complex, requiring users to manage multiple accounts and subscriptions. Consequently, users…
The Art of Simplifying Pharmacovigilance – Part II: Change Adoption
Considerable effort is dedicated to inputting clean adverse event data into a safety database, even before conducting the analysis to extract insights. In this scenario, manufacturers are investing more resources in the process of inputting data…
The Art of Simplifying Pharmacovigilance – Part I: Connecting the Dots
The Art of Simplifying Pharmacovigilance – Part I: Connecting the Dots In the intricate realm of pharmacovigilance, there is an art — a delicate dance of connecting the dots. Like a skilled painter, vigilant professionals adeptly…
Commercial Key Success Factors (KSFs) for Global Drug Development Programs
Key Contributors: Swapnil Waichale, Principal and Robin Arnold, Executive Vice President Discover the essential commercial key success Factors (KSFs) that drive triumph in global drug development programs. In an era of diverse regulatory perspectives and reimbursement…